Literature DB >> 19270631

Antipsychotics side effects' influence on stigma of mental illness: focus group study results.

Lan Novak1, Vesna Svab.   

Abstract

BACKGROUND: Little research was done on the influence of antipsychotics' side effects on stigma of mental illness. An overview of studies shows that people with mental illness state that because of medication side effects they feel discriminated in the field of employment, observe worsening of family relations and tend to skip or discontinue their regular medication. It is difficult to discriminate between stigmatizing effects of antipsychotics and other stigma related factors such as illness symptoms. SUBJECTS AND METHODS: A focus group of ten patients with schizophrenia or schizoaffective disorder with severe and remitting mental illness treated with antipsychotic medication was conducted to obtain their personal views on how side effects of antipsychotic drugs affect their everyday lives and contribute to the stigmatization because of mental illness.
RESULTS: The patients felt most stigmatized in areas of employment and occupation. They repeatedly skipped or discontinued regular medication due to side effects. Their families supported them throughout treatment and recovery despite problems associated with psychotropic medication.
CONCLUSION: Medication induced stigma affects patients' lives in substantial ways and therefore merits further research, part of which is the patients' personal experience.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270631

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  4 in total

1.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

Review 2.  Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis.

Authors:  Michael Townsend; Kristin Pareja; Amy Buchanan-Hughes; Emma Worthington; David Pritchett; Malaak Brubaker; Christy Houle; Tenna Natascha Mose; Heidi Waters
Journal:  Patient Prefer Adherence       Date:  2022-02-16       Impact factor: 2.711

3.  Risk and protective factors of relapse in patients with first-episode schizophrenia from perspectives of health professionals: a qualitative study in northeastern Thailand.

Authors:  Jarunee Intharit; Khanogwan Kittiwattanagul; Wisit Chaveepojnkamjorn; Kukiat Tudpor
Journal:  F1000Res       Date:  2021-06-25

4.  Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.

Authors:  Joseph Jankovic; Barbara Coffey; Daniel O Claassen; Joohi Jimenez-Shahed; Barry J Gertz; Elizabeth A Garofalo; David A Stamler; Maria Wieman; Juha-Matti Savola; Mark Forrest Gordon; Jessica Alexander; Hadas Barkay; Eran Harary
Journal:  JAMA Netw Open       Date:  2021-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.